CMS NCD Updates and Coding Revisions
CMS updates NCD coding for radiology and bone density, adding new ICD‑10 and CPT codes and revising Medicare billing rules.
Read moreThe Centers for Medicare and Medicaid Services (CMS) began transitioning participation in the traditional Merit-based Incentive Payment System (MIPS) to MIPS Value Pathways (MVPs) in 2023 to reduce the measure reporting burden (e.g., overall time spent toward activities related to clinical documentation, time spent in clinical review, administrative tasks) and streamline and simplify MIPS-eligible clinicians’ measure selection and reporting experience.
CMS said measures and activities included in MVPs must be linked by a condition or specialty topic so that care quality and associated costs may directly inform on value for patients and clinicians. Currently, radiologists participate in traditional MIPS because CMS has not finalized MVPs appropriate to the care they provide.
CMS shared a draft of the Diagnostic Radiology MVP earlier this year and met with American College of Radiology® (ACR®) measurement and economics leaders and staff. The College in response submitted a letter with feedback on the draft MVP, suggesting additional measures so that a wider range of MIPS-eligible radiologists could participate.
CMS released six candidate MVPs across multiple specialties Dec. 11, that it is considering for 2026 rulemaking, including Diagnostic Radiology and Interventional Radiology MVPs.
Parties interested in sharing MVP feedback must submit to PIMMSMVPSupport@gdit.com for consideration by 11:59 pm ET, Jan. 24. Emails should include:
If you have any questions or would like to share your comments about the Diagnostic Radiology and Interventional Radiology MVPs with the College, contact Samantha Shugarman, ACR Director of Quality Programs.
CMS NCD Updates and Coding Revisions
CMS updates NCD coding for radiology and bone density, adding new ICD‑10 and CPT codes and revising Medicare billing rules.
Read moreLegislation to Improve Lung Cancer Research for Women Advances
ACR applauded Senate passage of S.1157 to advance women’s lung cancer research, review care gaps, and improve outcomes. The bill awaits House-Senate alignment.
Read moreFDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read more